Caligan Partners LP
13F filer · CIK 0001727492Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$2.13BU.S. long equity reported on 13F
Positions255 new · 4 closed
Net flow last quarter+$39.1MBuys minus sells
Top 10 positions weight80.9%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202625 positions | |||||
| $647M | 30.45% | 9.11% | Not reported | Q4 2022 | |
| $367M | 17.28% | 0.92% | +18.7% | Q1 2025 | |
| $208M | 9.77% | 1.98% | +6.6% | Q4 2024 | |
| $127M | 5.99% | 1.51% | +6.2% | Q4 2025 | |
| $84.5M | 3.98% | 0.62% | Not reported | Q1 2023 | |
| $78.2M | 3.68% | 1.48% | +3.8% | Q4 2025 | |
| $58.5M | 2.75% | 5.98% | +93.5% | Q3 2025 | |
| $53.7M | 2.53% | 0.92% | -36.1% | Q3 2025 | |
| $47.9M | 2.25% | 2.54% | +20.4% | Q4 2022 | |
| $46.7M | 2.20% | 5.01% | Not reported | Q1 2026 | |
| $43.9M | 2.06% | 2.68% | New | Q2 2026 | |
| $40.3M | 1.90% | 1.94% | New | Q2 2026 | |
| $35.4M | 1.67% | 3.54% | Not reported | Q4 2025 | |
| $31.1M | 1.46% | 9.54% | Not reported | Q1 2026 | |
| $30.9M | 1.45% | 4.22% | +64.1% | Q4 2025 | |
| $30.5M | 1.44% | 4.15% | +1769.9% | Q2 2025 | |
| $25.8M | 1.21% | 1.35% | -36.8% | Q1 2025 | |
| $25M | 1.17% | 7.35% | 0.0% | Q1 2026 | |
| $21M | 0.99% | 10.72% | Not reported | Q4 2022 | |
| $19.3M | 0.91% | 8.15% | New | Q2 2026 | |
| $16.8M | 0.79% | 7.02% | New | Q2 2026 | |
| $15.7M | 0.74% | 2.44% | +399.6% | Q1 2026 | |
| $11M | 0.52% | 0.42% | -76.4% | Q1 2026 | |
| $5.65M | 0.27% | 5.38% | Not reported | Q3 2023 | |
| $1.31M | 0.06% | 5.70% | New | Q2 2026 | |
| Q1 2026Reported May 15, 202624 positions | |||||
| $306M | 20.39% | 9.19% | Not reported | Q4 2022 | |
| $163M | 10.83% | 1.86% | +0.7% | Q4 2024 | |
| $161M | 10.70% | 0.83% | +28.7% | Q1 2025 | |
| $120M | 7.97% | 1.43% | +20.9% | Q4 2025 | |
| $81M | 5.39% | 1.44% | +153.4% | Q3 2025 | |
| $75.1M | 5.00% | 3.36% | Not reported | Q2 2024 | |
| $66.6M | 4.43% | 0.60% | Not reported | Q1 2023 | |
| $50.4M | 3.35% | 1.67% | -35.4% | Q4 2025 | |
| $48.9M | 3.25% | 2.15% | +35.2% | Q1 2025 | |
| $44.3M | 2.95% | 1.11% | New | Q1 2026 | |
| $42.9M | 2.85% | 2.05% | +57.9% | Q4 2022 | |
| $34.6M | 2.30% | 5.02% | New | Q1 2026 | |
| $34.3M | 2.29% | 3.55% | +108.1% | Q4 2025 | |
| $30.5M | 2.03% | 10.52% | New | Q1 2026 | |
| $27.6M | 1.84% | 8.51% | New | Q1 2026 | |
| $27.6M | 1.84% | 2.57% | +148.8% | Q4 2025 | |
| $25.3M | 1.69% | 1.78% | New | Q1 2026 | |
| $24.4M | 1.62% | 6.64% | +85.5% | Q3 2025 | |
| $20.8M | 1.38% | 10.74% | Not reported | Q4 2022 | |
| $18.4M | 1.22% | 1.24% | +11.8% | Q4 2025 | |
| $4.89M | 0.33% | 5.38% | Not reported | Q3 2023 | |
| $3.97M | 0.26% | 9.40% | New | Q1 2026 | |
| $1.54M | 0.10% | 0.36% | Not reported | Q2 2025 | |
| $943K | 0.06% | 1.94% | New | Q1 2026 | |
| Q4 2025Reported Feb 17, 202620 positions | |||||
| $280M | 23.05% | 9.31% | Not reported | Q4 2022 | |
| $196M | 16.12% | 1.85% | Not reported | Q4 2024 | |
| $102M | 8.42% | 0.65% | +20.6% | Q1 2025 | |
| $101M | 8.28% | 3.40% | Not reported | Q2 2024 | |
| $78.7M | 6.48% | 1.30% | New | Q4 2025 | |
| $68.1M | 5.60% | 0.58% | +1.8% | Q1 2023 | |
| $54.9M | 4.52% | 1.27% | +14.3% | Q4 2022 | |
| $33M | 2.72% | 2.74% | New | Q4 2025 | |
| $25.6M | 2.10% | 2.22% | +36.9% | Q3 2025 | |
| $24.8M | 2.04% | 1.76% | +35.5% | Q1 2025 | |
| $24.6M | 2.03% | 0.69% | +23.6% | Q3 2025 | |
| $22.8M | 1.88% | 1.12% | New | Q4 2025 | |
| RTRAPTRAPT Therapeutics, Inc. | $21.8M | 1.80% | 2.33% | New | Q4 2025 |
| $16M | 1.32% | 4.76% | +5.8% | Q3 2025 | |
| $13.8M | 1.14% | 10.33% | Not reported | Q4 2022 | |
| $9.96M | 0.82% | 2.39% | New | Q4 2025 | |
| $9.3M | 0.77% | 1.04% | New | Q4 2025 | |
| $7.68M | 0.63% | 5.38% | Not reported | Q3 2023 | |
| $1.79M | 0.15% | 1.50% | New | Q4 2025 | |
| $840K | 0.07% | 0.74% | New | Q4 2025 | |
| Q3 2025Reported Nov 14, 202516 positions | |||||
| $185M | 24.18% | 9.35% | Not reported | Q4 2022 | |
| $123M | 16.14% | 2.29% | -13.3% | Q4 2024 | |
| $105M | 13.77% | 3.51% | +37.4% | Q2 2024 | |
| $63M | 8.25% | 0.57% | Not reported | Q1 2023 | |
| $49.7M | 6.51% | 0.56% | +67.1% | Q1 2025 | |
| $45.4M | 5.95% | 1.94% | +5.6% | Q4 2022 | |
| $38.7M | 5.06% | 1.11% | Not reported | Q4 2022 | |
| $25.4M | 3.33% | 6.39% | +23.9% | Q4 2022 | |
| MMRUSMerus N.V. | $20.4M | 2.68% | 0.29% | -67.0% | Q4 2024 |
| $17.8M | 2.34% | 0.58% | New | Q3 2025 | |
| $13.5M | 1.77% | 9.95% | Not reported | Q4 2022 | |
| $10.6M | 1.39% | 4.67% | New | Q3 2025 | |
| $9.75M | 1.28% | 1.31% | +266.9% | Q1 2025 | |
| $7.96M | 1.04% | 1.63% | New | Q3 2025 | |
| $3.98M | 0.52% | 9.74% | 0.0% | Q3 2023 | |
| $1.4M | 0.18% | 0.36% | +13.6% | Q2 2025 | |
Premium opens every quarter this fund has filed